Secondary sclerosing cholangitis after critical COVID-19: Three case reports

BACKGROUND: The global coronavirus disease 2019 (COVID-19) pandemic has caused more than 5 million deaths. Multiorganic involvement is well described, including liver disease. In patients with critical COVID-19, a new entity called "post-COVID-19 cholangiopathy" has been described. CASE SU...

Descripción completa

Detalles Bibliográficos
Autores principales: Mayorquín-Aguilar, Juan M, Lara-Reyes, Aldo, Revuelta-Rodríguez, Luis Alberto, Flores-García, Nayelli C, Ruiz-Margáin, Astrid, Jiménez-Ferreira, Marco Antonio, Macías-Rodríguez, Ricardo Ulises
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9453459/
https://www.ncbi.nlm.nih.gov/pubmed/36157873
http://dx.doi.org/10.4254/wjh.v14.i8.1678
Descripción
Sumario:BACKGROUND: The global coronavirus disease 2019 (COVID-19) pandemic has caused more than 5 million deaths. Multiorganic involvement is well described, including liver disease. In patients with critical COVID-19, a new entity called "post-COVID-19 cholangiopathy" has been described. CASE SUMMARY: Here, we present three patients with severe COVID-19 that subsequently developed persistent cholestasis and chronic liver disease. All three patients required intensive care unit admission, mechanical ventilation, vasopressor support, and broad spectrum antibiotics due to secondary infections. Liver transplant protocol was started for two of the three patients. CONCLUSION: Severe COVID-19 infection should be considered a potential risk factor for chronic liver disease and liver transplantation.

Ejemplares similares